US4081530A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Extended chain derivatives of somatostatin
Assignee: Wyeth Canada Inc
•
Filing: 1975-06-04
•
Granted: 1978-03-28
•
Expires: 1995-06-04
Abstract
Abstract Compounds of the formula 1 or 1a ##STR1## wherein R 1 is H--, H--Gly or H--Leu and R 2 is H or COOH and pharmaceutically acceptable salts thereof, are disclosed. The compounds of formulae 1 and 1a are useful for the management of diabetes and the treatment of acromegaly. Methods for their use are also disclosed.
Inventors
- 👤 Hans U. Immer
- 👤 Verner R. Nelson
- 👤 Kazimir Sestanj
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-04 23:53
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/575; C07K14/655; C07K5/00; C07K5/04; C07K5/10; C07K5/1002; C07K5/1005; C07K5/1008; A; A61; A61K; A61K38/00; Y; Y10; Y10S; Y10S930/00; Y10S930/01; Y10S930/16
Claims Analysis
Total Claims: 33
Claim 1
Independent Claim
191 words
A process for preparing a peptide of formula I ##STR139## in which R 1 is hydrogen, H-Gly or H-Leu and R 2 is hydrogen or carboxyl, which comprises: oxidizing a linear peptide of formula ##STR140## in which R 3 is Boc, Boc-Gly or Boc-Leu and R 2 is hydrogen or carboxyl with iodine or thiocyanogen to obtain the corresponding cyclic disulfide derivative of formula ##STR141## in which R 2 and R 3 are as defined herein and subsequently removing all remaining protecting groups under moderately acidic conditions to obtain the corresponding peptide of formula I; or followed by subjecting said linear peptide to treatment with either mercuric acetate, mercuric chloride, silver acetate or silver nitrate to remove selectively the sulfhydryl protecting groups to obtain the mercuric or disilver salt, respectively, of the corresponding disulfhydryl derivative; converting the latter salt to its corresponding free disulfhydryl derivative by treatment with hydrogen sulfide, oxidizing said last-named disulfhydryl derivative by treatment with oxygen, 1,2-diiodoethane, sodium or potassium ferricyanide or iodine to obtain the corresponding cyclic disulfide derivative and removing the remaining protecting groups under moderately acidic conditions and isolating the desired peptide of formula I.
Claim 2
Dependent Claim
191 words
A process for preparing a peptide of formula I ##STR139## in which R 1 is hydrogen, H-Gly or H-Leu and R 2 is hydrogen or carboxyl, which comprises: oxidizing a linear peptide of formula ##STR140## in which R 3 is Boc, Boc-Gly or Boc-Leu and R 2 is hydrogen or carboxyl with iodine or thiocyanogen to obtain the corresponding cyclic disulfide derivative of formula ##STR141## in which R 2 and R 3 are as defined herein and subsequently removing all remaining protecting groups under moderately acidic conditions to obtain the corresponding peptide of formula I; or followed by subjecting said linear peptide to treatment with either mercuric acetate, mercuric chloride, silver acetate or silver nitrate to remove selectively the sulfhydryl protecting groups to obtain the mercuric or disilver salt, respectively, of the corresponding disulfhydryl derivative; converting the latter salt to its corresponding free disulfhydryl derivative by treatment with hydrogen sulfide, oxidizing said last-named disulfhydryl derivative by treatment with oxygen, 1,2-diiodoethane, sodium or potassium ferricyanide or iodine to obtain the corresponding cyclic disulfide derivative and removing the remaining protecting groups under moderately acidic conditions and isolating the desired peptide of formula I.
Claim 3
Dependent Claim
124 words
A process as claimed in claim 1 in which the linear peptide of formula ##STR142## in which R 2 and R 3 are as defined therein is prepared by reacting according to the azide coupling method a pentapeptide of formula ##STR143## with a peptide of formula ##STR144## in which R 2 is as defined therein to obtain the corresponding peptide of formula ##STR145## removing the terminal amino protecting group (Trt) of said last-named compound under mildly acidic conditions to obtain the corresponding peptide of formula ##STR146## in which R 2 is as defined therein; followed by reacting said last-named compound with R 3 -Gly-Gly-Als-Gly-NHNH 2 in which R 3 is as defined therein according to the azide coupling method and isolating said linear peptide.
Claim 4
Dependent Claim
141 words
A process as claimed in claim 1 in which the linear peptide of formula ##STR147## in which R 2 and R 3 are as defined therein is prepared by reacting according to the azide coupling method a peptide of formula R 3 -Gly-Gly-Ala-Gly-NHNH 2 in which R 3 is as defined therein with a pentapeptide of formula ##STR148## to obtain the corresponding peptide of formula ##STR149## in which R 3 is as defined therein, followed by reacting said last-named compound with hydrazine hydrate to obtain the corresponding peptide of formula ##STR150## in which R 3 is as defined therein and reacting said last-named compound with a peptide of formula ##STR151## in which R 2 is as defined therein according to the azide coupling method and isolating said linear peptide, ##STR152## in which R 2 and R 3 are as defined therein.
Claim 5
Dependent Claim
44 words
The process as claimed in claim 1 wherein said linear peptide is subjected to treatment with iodine at from about 0° to 30° C for about 30 to 180 minutes in a lower alkanol or acetic acid to obtain the corresponding cyclic disulfide derivative.
Claim 6
Dependent Claim
25 words
A compound of the formula I or Ia ##STR153## in which R 1 is hydrogen, H-Gly or H-Leu and R 2 is hydrogen or carboxyl.
Claim 7
Dependent Claim
25 words
A compound of the formula I or Ia ##STR153## in which R 1 is hydrogen, H-Gly or H-Leu and R 2 is hydrogen or carboxyl.
Claim 8
Dependent Claim
16 words
The compound of claim 5 in which R 1 is hydrogen and R 2 is carboxyl.
Claim 9
Dependent Claim
16 words
The compound of claim 5 in which R 1 is H-Gly and R 2 is hydrogen.
Claim 10
Dependent Claim
16 words
The compound of claim 5 in which R 1 is H-Gly and R 2 is carboxyl.
Claim 11
Dependent Claim
16 words
The compound of claim 5 in which R 1 is H-Leu and R 2 is hydrogen.
Claim 12
Dependent Claim
16 words
The compound of claim 5 in which R 1 is H-Leu and R 2 is carboxyl.
Claim 13
Dependent Claim
16 words
The compound of claim 5 in which R 1 is hydrogen and R 2 is hydrogen.
Claim 14
Dependent Claim
21 words
A compound of formula ##STR154## in which R 2 is hydrogen or carboxyl and R 3 is Boc, Boc-Gly or Boc-Leu.
Claim 15
Dependent Claim
21 words
A compound of formula ##STR154## in which R 2 is hydrogen or carboxyl and R 3 is Boc, Boc-Gly or Boc-Leu.
Claim 16
Dependent Claim
16 words
The compound of claim 12 in which R 2 is carboxyl and R 3 is Boc.
Claim 17
Dependent Claim
16 words
The compound of claim 12 in which R 2 is hydrogen and R 3 is Boc-Gly.
Claim 18
Dependent Claim
16 words
The compound of claim 12 in which R 2 is carboxyl and R 3 is Boc-Gly.
Claim 19
Dependent Claim
16 words
The compound of claim 12 in which R 2 is hydrogen and R 3 is Boc-Leu.
Claim 20
Dependent Claim
16 words
The compound of claim 12 in which R 2 is carboxyl and R 3 is Boc-Leu.
Claim 21
Dependent Claim
16 words
The compound of claim 12 in which R 2 is hydrogen and R 3 is Boc.
Claim 22
Dependent Claim
16 words
A compound of the formula ##STR155## in which R 3 , is Boc, Boc-Gly or Boc-Leu.
Claim 23
Dependent Claim
16 words
A compound of the formula ##STR155## in which R 3 , is Boc, Boc-Gly or Boc-Leu.
Claim 24
Dependent Claim
19 words
A pharmaceutically acceptable acid addition salt of the compound of formula I or Ia as claimed in claim 5.
Claim 25
Dependent Claim
14 words
The acid addition salt of claim 20 in which the acid is hydrochloric acid.
Claim 26
Dependent Claim
14 words
The acid addition salt of claim 20 in which the acid is acetic acid.
Claim 27
Dependent Claim
42 words
A method of treating acromegaly in a mammal which comprises administering to said mammal an effective dose of a compound of formula I or Ia as claimed in claim 5 or a pharmaceutically acceptable salt thereof together with a pharmaceutically acceptable carrier.
Claim 28
Dependent Claim
26 words
A pharmaceutical composition comprising a compound of formula I or Ia as claimed in claim 5 or a pharmaceutically acceptable salt thereof and pharmaceutically acceptable carrier.
Claim 29
Dependent Claim
41 words
A method of treating diabetes in a mammal which comprises administering to said mammal an effective dose of compound of formula I or Ia as claimed in claim 5 or a pharmaceutically acceptable salt thereof together with a pharmaceutically acceptable carrier.
Claim 30
Dependent Claim
13 words
A compound of formula ##STR156## in which R 2 is hydrogen or carboxyl.
Claim 31
Dependent Claim
13 words
A compound of formula ##STR156## in which R 2 is hydrogen or carboxyl.
Claim 32
Dependent Claim
18 words
A compound of the formula R 3 -Gly-Gly-Ala-Gly-NHNH 2 in which R 3 is Boc, Boc-Gly or Boc-Leu.
Claim 33
Dependent Claim
18 words
A compound of the formula R 3 -Gly-Gly-Ala-Gly-NHNH 2 in which R 3 is Boc, Boc-Gly or Boc-Leu.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1981-03-27 | 1981-09-26 | 1982-03-28 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1985-03-27 | 1985-09-26 | 1986-03-28 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1989-03-27 | 1989-09-26 | 1990-03-28 | $7700.00 | Window Closed / Lapsed |